Whole Exome Sequencing Market to Reach USD 773 Million by 2031, Driven by 11.4% CAGR | Global Genomic Research Growth Outlook 2025-2031

The global Whole Exome Sequencing market is broadly studied in the report with large focus on market competition, segmentation, geographical expansion, and other important aspects. The analysts who have prepared the report are highly experienced in market research and possess vast knowledge about the global Whole Exome Sequencing market. The report includes deep analysis of microeconomic and macroeconomic factors impacting the growth of the global Whole Exome Sequencing market. It also offers analysis of production, sales, and consumption growth in the global Whole Exome Sequencing market. With the help of exhaustive research studies provided in the report, readers can easily become familiar with key dynamics of the global Whole Exome Sequencing market, including drivers, restraints, and opportunities.

The global Whole Exome Sequencing market was valued at US$ 367 million in 2024 and is anticipated to reach US$ 773 million by 2031, witnessing a CAGR of 11.4% during the forecast period 2025-2031.

Download Exclusive PDF Sample: (Including Full TOC, Data Tables, Visual Charts) @ https://www.qyresearch.in/request-sample/pharma-healthcare-global-whole-exome-sequencing-market-insights-industry-share-sales-projections-and-demand-outlook-2025-2031

Exome sequencing is a capture based method developed to identify variants in the coding region of genes which affect protein function. While exome capture methods using PCR, hybrid capture and molecular inversion probes exist, the most common and efficient strategies are in-solution capture methods. In-solution capture utilizes pools of oligonucleotides or probes bound to magnetic beads, whose sequence has been designed to hybridize to exon regions. After binding to genomic DNA, these probes are pulled down and washed, allowing exon regions to be selectively sequenced.

While there are approximately 180,000 exons in the human genome, constituting less than 2% of total sequence, the exome contains ~80-90% of known disease causing variants making it a cost-effective alternative to whole genome sequencing. When performing exome-seq, users should not only consider average on-target coverage but also the local coverage of particular sites of interest. When choosing between exome and whole genome sequencing (WGS), consider that exome sequencing has the advantage that oligonucleotides are designed to particular genomic regions where typical coverage with WGS is not enough for SNP calling. It is also more affordable enabling the analysis of more individuals and populations. With WGS, you can detect variants in regions not covered by exome capture allowing or the identification of structural and non-coding variants associated with disease.

The major players in global Whole Exome Sequencing market include Illumina, Thermofisher, Roche, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 70% of the global market. Illumina TruSeq Exome and Roche Nimblegen SeqCap are main types, with a share about 55%. Mendelian Disease and Rare Syndrome Gene Discovery are the main application, which hold a share about 40%.

Competitive landscape is one of the most interesting subjects of any market research study. It provides readers with important information on competition trends, prominent players, and nature of competition. In this report, the authors have profiled some of the top-ranking as well as other players of the global Whole Exome Sequencing market. In the company profiling section, each player is comprehensively studied while focusing on its market share, recent developments, production, gross revenue, profit margin, and other factors. The competitive analysis shared in the report will help players to improve their strategies to better compete with other companies.

Key Players Dominating the Global Whole Exome Sequencing Markets are:

Illumina
Thermo Fisher
Roche
Angilent
Eurofins
Sengenics
Ambry
Macrogen
BGI
Novo Gene

All of the segments of the global Whole Exome Sequencing market analyzed in the report are deeply studied while concentrating on their market share, CAGR, and growth opportunities. The segmentation study provided in the report will help players to identify rewarding growth prospects available in the global Whole Exome Sequencing market. Furthermore, it offers a clear and thorough evaluation of key segments so that players could bank on profit-making areas of the global Whole Exome Sequencing market. The analysts have explained each factor contributing to the growth of leading segments. In addition, they have provided a near-accurate prediction of the growth potential of each segment.

Segment by Type

Agilent HaloPlex
Agilent SureSelect
Agilent SureSelect QXT
Illumina TruSeq Exome
Roche Nimblegen SeqCap
MYcroarray MYbaits

Segment by Application

Correlation Research of Normal Human
Mendelian Disease and Rare Syndrome Gene Discovery
The Research of Complex Diseases
Mouse Exome Sequencing

The segment of the market features the areas that are secured under the global Whole Exome Sequencing market are North America, South East Asia, Japan, India, China, and Europe. The regional analysis provided in the research study is an outstanding attempt made by the researchers to help players identify high-growth regions and modify their strategies according to the specific market scenarios therein. Each region is deeply analyzed with large focus on CAGR, market growth, market share, market situations, and growth forecast.

Segment by Region

North America
U.S.
Canada

Europe
Germany
France
U.K.
Italy
Russia

Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia

Latin America
Mexico
Brazil
Argentina

Middle East & Africa
Turkey
Saudi Arabia
UAE

Methodology and Data Sources

The researchers used reliable primary and secondary information and data sources to compile the report. As part of the primary research process, they personally interviewed important entities and companies from the supply as well as demand side of the industry. These include key executives, innovation specialists, technology experts, marketing managers, vice presidents, chief financial officers, and chief executives. For secondary research, the analysts used articles by popular authors, company financial reports, quarterly and annual earnings presentations, web data, information from government and regulatory databases, and official journals.

The researchers used some important parameters for market forecasting: future capacity additions, current capacity, anticipated developments in the market and the industry, regulatory scenarios, price trends, supply and demand trends, raw material scenarios, key drivers and restraints, and their predicted impact on the global market.

Request Pre-Order Enquiry on This Exclusive Report @ https://www.qyresearch.in/pre-order-inquiry/pharma-healthcare-global-whole-exome-sequencing-market-insights-industry-share-sales-projections-and-demand-outlook-2025-2031

Market Report Objectives

(1) Analyzing the size of the global Whole Exome Sequencing market on the basis of value and volume

(2) Accurately calculating the market shares, consumption, and other vital factors of different segments of the global Whole Exome Sequencing market

(3) Exploring key dynamics of the global Whole Exome Sequencing market

(4) Highlighting important trends of the global Whole Exome Sequencing market in terms of production, revenue, and sales

(5) Deeply profiling top players of the global Whole Exome Sequencing market and showing how they compete in the industry

(6) Studying manufacturing processes and costs, product pricing, and various trends related to them

(7) Showing the performance of different regions and countries in the global Whole Exome Sequencing market

(8) Forecasting the market size and share of all segments, regions, and the global market.

Key Questions Answered in the Market Research Report

(A) Which are the five top players of the global Whole Exome Sequencing market?

(B) How will the global Whole Exome Sequencing market change in the next five years

(C) Which product and application will take a lion's share of the global Whole Exome Sequencing market?

(D) What are the drivers and restraints of the global Whole Exome Sequencing market?

(E)Which regional market will show the highest growth?

(F) What will be the CAGR and size of the global Whole Exome Sequencing market throughout the forecast period?

Other Related Report From QY Research:

https://www.qyresearch.in/report-details/9203615/Global-Rivaroxaban-Market-Insights

https://www.qyresearch.in/report-details/8302415/Global-Vaccines-Market-Insights

https://www.qyresearch.in/report-details/5102367/Global-Commercializing-Biomarkers-in-Therapeutic-and-Diagnostic-Applications-Market-Insights

https://www.qyresearch.in/report-details/6142579/Global-Food-Animal-Eubiotics-Market-Insights

https://www.qyresearch.in/report-details/3501792/Global-General-Anesthesia-Drugs-Market-Insights

Contact US

QY RESEARCH, INC.
17890 CASTLETON STREET
SUITE 369, CITY OF INDUSTRY
CA - 91748, UNITED STATES OF AMERICA
Web - https://www.qyresearch.in
Tel: +91-8149736330
Email- ankit@qyresearch.com

About US:

QYResearch is a leading global market research and consulting company established in 2007. With over 17 years' experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability.

This release was published on openPR.